Technical Manager
Perspective Therapeutics
Technical Manager
Perspective Therapeutics
Clinical-stage radiopharmaceuticals using targeted alpha therapies
Clinical-stage radiopharmaceuticals using targeted alpha therapies
Perspective Therapeutics develops targeted alpha-particle radiopharmaceuticals for cancer, using Lead-212 attached to tumor-targeting peptides and paired Lead-203 imaging for patient selection. It delivers potent alpha radiation to cancer cells to induce DNA damage while protecting healthy tissue, enabling theranostic treatment planning. The company differentiates itself with in-house development, a vertically integrated manufacturing and supply chain, and a radiopharmaceutical facility in New Jersey, plus a strategic partnership with Lantheus for funding and co-development. Its goal is to advance isotope-based cancer therapies from discovery to commercialization by building a reliable isotope supply network and expanding its therapeutic and diagnostic offerings.
Explore more opportunities at Perspective Therapeutics